Medicare Enrolled
Dr. Frank Rubalcava, MD
Cardiovascular Disease · New Braunfels, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubalcava from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubalcava?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubalcava
Dr. Frank Rubalcava is a cardiovascular disease specialist in New Braunfels, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rubalcava performed 8,491 Medicare services across 6,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubalcava received a total of $7,796 from 32 pharmaceutical and/or device companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubalcava is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in TX
$7,796 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,491
Medicare services
Top 5% in TX for cardiovascular disease
6,122
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~425 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,446 | $83 | $388 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,011 | $10 | $72 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
664 | $13 | $60 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
515 | $4 | $23 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
403 | $135 | $1,003 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
372 | $46 | $152 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
371 | $8 | $18 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
345 | $13 | $39 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
342 | $134 | $661 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $66 | $233 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
274 | $38 | $156 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
260 | $47 | $136 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
251 | $2 | $11 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
251 | $2 | $11 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
224 | $61 | $217 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
186 | $4 | $26 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
164 | $49 | $372 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
123 | $335 | $1,741 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
121 | $6 | $55 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
121 | $57 | $517 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
114 | $29 | $126 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
107 | $135 | $570 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
94 | $19 | $129 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
68 | $36 | $120 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
47 | $173 | $867 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $73 | $335 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
38 | $101 | $394 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
29 | $39 | $109 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
26 | $5 | $15 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
26 | $130 | $705 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
24 | $26 | $232 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
20 | $177 | $806 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
20 | $24 | $103 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
17 | $18 | $70 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
15 | $9 | $44 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
15 | $41 | $171 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
15 | $44 | $209 |
| Troponin blood test A blood test that measures the amount of troponin protein in your body. Troponin is released into the blood when heart muscle is damaged. |
14 | $12 | $44 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
14 | $16 | $68 |
| Myoglobin level test A blood test that measures the amount of myoglobin, a protein found in muscle tissue, in the body. |
13 | $13 | $73 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
11 | $207 | $907 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
14.2% medium
77.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,796
Total received (2018-2024)
Avg $1,114/year across 7 years
Top 38% in TX for cardiovascular disease
32
Companies
375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,796 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$563
2023
$728
2022
$990
2021
$1,528
2020
$669
2019
$1,483
2018
$1,834
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,527
BOSTON SCIENTIFIC CORPORATION
$1,006
Abbott Laboratories
$543
Novartis Pharmaceuticals Corporation
$540
Boston Scientific Corporation
$493
PFIZER INC.
$410
Amarin Pharma Inc.
$404
Amgen Inc.
$307
Merck Sharp & Dohme LLC
$276
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$265
SANOFI-AVENTIS U.S. LLC
$259
Biosense Webster, Inc.
$209
Esperion Therapeutics, Inc.
$181
AstraZeneca Pharmaceuticals LP
$166
iRhythm Technologies, Inc.
$162
Edwards Lifesciences Corporation
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Kowa Pharmaceuticals America, Inc.
$95
Inari Medical, Inc.
$93
Akcea Therapeutics, Inc.
$88
Medtronic Vascular, Inc.
$79
Relypsa, Inc.
$73
AngioDynamics, Inc.
$72
Merck Sharp & Dohme Corporation
$66
Allergan Inc.
$52
Regeneron Healthcare Solutions, Inc.
$37
E.R. Squibb & Sons, L.L.C.
$32
CVRx, Inc.
$32
Braemar Manufacturing, LLC
$19
ARALEZ PHARMACEUTICALS US INC.
$13
Otsuka America Pharmaceutical, Inc.
$12
Aziyo Biologics, Inc.
$9
Top 3 companies account for 39.5% of total payments
Associated products mentioned in payments ›
ALLURE QUADRA · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Assurity Pacemaker · BRILINTA · BYSTOLIC · Barostim Neo System · CARDIOMEMS · CHANTIX · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 System · Confirm Rx · Corlanor · ECM · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · GALLANT · GENERAL TACHY · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL METALLIC STENTS · GENERAL TACHY · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · HeartMate · HeartMate 3 Left Ventricular Assist Device · JARDIANCE · LATITUDE · LEQVIO · LUX DX · LifeVest · Livalo · MULTAQ · NEXLETOL · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · Repatha · Reveal LINQ · S · SAMSCA · SAPIEN 3 Ultra RESILIA · TEGSEDI · UNIFY ASSURA · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · XARELTO · Xience Sierra Coronary Stent · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $92 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
34
Per 100K population
19.1
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rubalcava is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rubalcava experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rubalcava performed 1,446 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubalcava receive payments from pharmaceutical companies?
Yes. Dr. Rubalcava received a total of $7,796 from 32 companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubalcava's costs compare to other cardiologists in New Braunfels?
Dr. Rubalcava's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubalcava) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New Braunfels
Browse cardiologists in New Braunfels ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology